Lista de obras -

"Alzheimer's 101"

artículo científico publicado en 2007

18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery

artículo científico publicado en 2018

2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease

artículo científico publicado en 2014

A chapter in the development of Alzheimer's disease research: a case study of public policies on the development and funding of research programs

artículo científico

A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.

artículo científico publicado en 2009

A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium

artículo científico publicado en 2008

Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit

artículo científico publicado en 2012

Aging: a Cause or a Risk for AD?

artículo científico publicado en 2000

Alzheimer's & Dementia: the Journal of the Alzheimer's Association

artículo científico publicado en 2008

Alzheimer's Association Research Roundtable Meeting on Mild Cognitive Impairment: what have we learned?

scientific article published on July 2006

Application of Systems Theory in Longitudinal Studies on the Origin and Progression of Alzheimer's Disease

artículo científico publicado en 2016

Barriers to drug discovery and development for Alzheimer disease.

artículo científico publicado en 2002

Big data to smart data in Alzheimer's disease: The brain health modeling initiative to foster actionable knowledge

artículo científico publicado en 2016

Big data, aging, and dementia: pathways for international harmonization on data sharing

artículo científico publicado en 2013

Biomarker development: a population-level perspective

scientific article published on 01 July 2012

Common threads in neurodegenerative disorders of aging

Creating a transatlantic research enterprise for preventing Alzheimer's disease

artículo científico publicado en 2009

Designing drug trials for Alzheimer's disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force ⬇️

artículo científico publicado el 1 de julio de 2013

Developing a global strategy to prevent Alzheimer's disease: Leon Thal Symposium 2010.

artículo científico publicado en 2011

Developing a national strategy to prevent dementia: Leon Thal Symposium 2009.

artículo científico publicado en 2010

Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot

artículo científico

Diagnosis of Alzheimer's disease: two decades of progress

artículo científico publicado en 2005

Diagnosis of Alzheimer's disease: two-decades of progress

artículo científico publicado en 2006

Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit

artículo científico publicado en 2016

Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development

artículo científico

Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework

artículo científico publicado en 2018

Healthy aging and preclinical dementia: the United States-Israel Longitudinal Database project

artículo científico publicado en 2010

History of Alzheimer's research: the politics of science in building a national program of research

artículo científico publicado en 2006

In silico modeling system: a national research resource for simulation of complex brain disorders

scientific article published on 01 January 2009

Leon Joel Thal, MD, 1944-2007: honoring his scientific legacy

artículo científico publicado en 2007

Massachusetts Alzheimer's Disease Research Center: progress and challenges

artículo científico publicado en 2015

Methodological issues in primary prevention trials for neurodegenerative dementia

artículo científico publicado en 2009

Military risk factors for Alzheimer's dementia and neurodegenerative disease

artículo científico publicado en 2014

Models and modeling systems in Alzheimer disease drug discovery

artículo científico publicado en 2002

NAPA 2.0: The next giant leap ⬇️

artículo científico publicado el 1 de septiembre de 2012

Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020.

artículo científico publicado en 2013

Perspective on the "2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease"

artículo científico publicado en 2014

Perspective on the Alzheimer's disease neuroimaging initiative: progress report and future plans.

artículo científico publicado en 2010

Politics of science: Progress toward prevention of the dementia-Alzheimer's syndrome

artículo científico

Prevent Alzheimer's disease by 2020: a national strategic goal

artículo científico publicado en 2009

Prospects for designating Alzheimer's disease research a national priority ⬇️

artículo científico publicado el 1 de noviembre de 2011

Public health premise for national research priorities: mortality versus disability

scientific article published on 01 July 2005

Revised criteria for diagnosis of Alzheimer's disease: National Institute on Aging‐Alzheimer's Association diagnostic guidelines for Alzheimer's disease ⬇️

artículo científico publicado el 1 de mayo de 2011

Revisiting the cholinergic hypothesis in Alzheimer's disease: Emerging evidence from translational and clinical research

artículo científico publicado en 2017

Revisiting the framework of the National Institute on Aging-Alzheimer's Association diagnostic criteria

artículo científico publicado en 2013

Robert Katzman: the man and his legacy

artículo científico publicado en 2008

Scope and aims of Alzheimer's & Dementia: the Journal of the Alzheimer's Association

artículo científico publicado en 2005

Subjective Cognitive Decline Is Associated With Altered Default Mode Network Connectivity in Individuals With a Family History of Alzheimer's Disease

scholarly article by Sander C.J. Verfaillie et al published May 2018 in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging

The Nevada Vital Aging Initiative: A private-public partnership to study early predictors of dementia

artículo científico publicado en 2007

The Special Topics Section of Alzheimer's & Dementia

artículo científico publicado en 2015

The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier)

artículo científico publicado en 2013

The challenges of developing and validating molecular and biochemical markers of Alzheimer's disease

artículo científico publicado en 2002

The cholinergic system in the pathophysiology and treatment of Alzheimer's disease

scholarly article by Harald Hampel et al published 1 July 2018 in Brain

The crisis in recruitment for clinical trials in Alzheimer's and dementia: An action plan for solutions

artículo científico publicado en 2016

The draft “National Plan” to address Alzheimer's disease ‐ National Alzheimer's Project Act (NAPA) ⬇️

artículo científico publicado el 1 de mayo de 2012

Toward a consensus recommendation for defining the asymptomatic-preclinical phases of putative Alzheimer's disease?

artículo científico publicado en 2016

When will dementia become a curable disease and Alzheimer's a forgotten word?

artículo científico publicado en 2006

Zenith Award Program of the Alzheimer's Association

artículo científico publicado en 2007

Zeroing out preventable disability: Daring to dream the impossible dream for dementia care: Recommendations for a national plan to advance dementia care and maximize functioning

artículo científico publicado en 2017

Lista de obras de

"Alzheimer's 101"

18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery

2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease

A chapter in the development of Alzheimer's disease research: a case study of public policies on the development and funding of research programs

A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.

A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium

Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit

Aging: a Cause or a Risk for AD?

Alzheimer's & Dementia: the Journal of the Alzheimer's Association

Alzheimer's Association Research Roundtable Meeting on Mild Cognitive Impairment: what have we learned?

Application of Systems Theory in Longitudinal Studies on the Origin and Progression of Alzheimer's Disease

Barriers to drug discovery and development for Alzheimer disease.

Big data to smart data in Alzheimer's disease: The brain health modeling initiative to foster actionable knowledge

Big data, aging, and dementia: pathways for international harmonization on data sharing

Biomarker development: a population-level perspective

Common threads in neurodegenerative disorders of aging

Creating a transatlantic research enterprise for preventing Alzheimer's disease

Designing drug trials for Alzheimer's disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force ⬇️

Developing a global strategy to prevent Alzheimer's disease: Leon Thal Symposium 2010.

Developing a national strategy to prevent dementia: Leon Thal Symposium 2009.

Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot

Diagnosis of Alzheimer's disease: two decades of progress

Diagnosis of Alzheimer's disease: two-decades of progress

Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit

Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development

Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework

Healthy aging and preclinical dementia: the United States-Israel Longitudinal Database project

History of Alzheimer's research: the politics of science in building a national program of research

In silico modeling system: a national research resource for simulation of complex brain disorders

Leon Joel Thal, MD, 1944-2007: honoring his scientific legacy

Massachusetts Alzheimer's Disease Research Center: progress and challenges

Methodological issues in primary prevention trials for neurodegenerative dementia

Military risk factors for Alzheimer's dementia and neurodegenerative disease

Models and modeling systems in Alzheimer disease drug discovery

NAPA 2.0: The next giant leap ⬇️

Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020.

Perspective on the "2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease"

Perspective on the Alzheimer's disease neuroimaging initiative: progress report and future plans.

Politics of science: Progress toward prevention of the dementia-Alzheimer's syndrome

Prevent Alzheimer's disease by 2020: a national strategic goal

Prospects for designating Alzheimer's disease research a national priority ⬇️

Public health premise for national research priorities: mortality versus disability

Revised criteria for diagnosis of Alzheimer's disease: National Institute on Aging‐Alzheimer's Association diagnostic guidelines for Alzheimer's disease ⬇️

Revisiting the cholinergic hypothesis in Alzheimer's disease: Emerging evidence from translational and clinical research

Revisiting the framework of the National Institute on Aging-Alzheimer's Association diagnostic criteria

Robert Katzman: the man and his legacy

Scope and aims of Alzheimer's & Dementia: the Journal of the Alzheimer's Association

Subjective Cognitive Decline Is Associated With Altered Default Mode Network Connectivity in Individuals With a Family History of Alzheimer's Disease

The Nevada Vital Aging Initiative: A private-public partnership to study early predictors of dementia

The Special Topics Section of Alzheimer's & Dementia

The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier)

The challenges of developing and validating molecular and biochemical markers of Alzheimer's disease

The cholinergic system in the pathophysiology and treatment of Alzheimer's disease

The crisis in recruitment for clinical trials in Alzheimer's and dementia: An action plan for solutions

The draft “National Plan” to address Alzheimer's disease ‐ National Alzheimer's Project Act (NAPA) ⬇️

Toward a consensus recommendation for defining the asymptomatic-preclinical phases of putative Alzheimer's disease?

When will dementia become a curable disease and Alzheimer's a forgotten word?

Zenith Award Program of the Alzheimer's Association

Zeroing out preventable disability: Daring to dream the impossible dream for dementia care: Recommendations for a national plan to advance dementia care and maximize functioning